Nationwide population-based infection- and vaccine-induced SARS-CoV-2 seroprevalence in Germany at the end of 2021

Elisabetta Mercuri, Lorenz Schmid, Christina Poethko-Müller, Martin Schlaud, Cânâ Kußmaul, Ana Ordonez-Cruickshank, Sebastian Haller, Ute Rexroth, Osamah Hamouda, Lars Schaade, Lothar H. Wieler, Antje Gößwald, Angelika Schaffrath Rosario, the RKI-SOEP-2 Study Group
doi: https://doi.org/10.1101/2023.10.30.23297594

Article usage

Article usage: October 2023 to November 2024

AbstractFullPdf
Oct 2023167010
Nov 202326420109
Dec 20232718
Jan 202424211
Feb 20242806
Mar 20242303
Apr 20242154
May 202423717
Jun 20241737
Jul 202429411
Aug 202426410
Sep 2024401019
Oct 20241959
Nov 202455517
Back to top
Posted October 31, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Nationwide population-based infection- and vaccine-induced SARS-CoV-2 seroprevalence in Germany at the end of 2021
Elisabetta Mercuri, Lorenz Schmid, Christina Poethko-Müller, Martin Schlaud, Cânâ Kußmaul, Ana Ordonez-Cruickshank, Sebastian Haller, Ute Rexroth, Osamah Hamouda, Lars Schaade, Lothar H. Wieler, Antje Gößwald, Angelika Schaffrath Rosario, the RKI-SOEP-2 Study Group
medRxiv 2023.10.30.23297594; doi: https://doi.org/10.1101/2023.10.30.23297594
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area